
Jan 12 (Reuters) - Erasca Inc ERAS.O:
ERASCA INC - REPORTS PROMISING EARLY CLINICAL DATA FOR ERAS-0015
ERASCA INC - PLANS PHASE 1 DATA RELEASE FOR ERAS-0015 AND ERAS-4001 IN 2026
ERASCA INC - REPORTS FAVORABLE SAFETY AND TOLERABILITY FOR ERAS-0015
ERASCA INC - PLANS PHASE 1 DATA FOR KRAS-MUTANT TUMORS IN H2 2026